Omada Health provides digital care with a human touch for chronic diseases such as heart disease and hypertension. Omada pairs its participants with live coaches via its telehealth platform, enabling medical-care providers to increase their reach while keeping costs down. As the largest CDC-recognized provider taking part in the National Diabetes Prevention Program, Omada works with Medicaid programs, community health centers and others to help over 350,000 at-risk participants prevent the onset of Type 2 diabetes. Recently Omada acquired Physera for $30 million, adding physical therapy to its portfolio of digital care programs for common high-cost conditions. Omada is not only a leader in tech and machine learning–the San Francisco-based company has published 14 peer-reviewed studies overall demonstrating the effectiveness of its work. Omada reports a valuation of $600 million and has raised over $250 million; its backers include the venture arms of healthcare providers, including Cigna Ventures and Kaiser Permanente Ventures.
|No. of employees (approximate)||500|
|Investors||Andreessen Horowitz, Norwest Venture Partners, U.S. Venture Partners, Cigna Ventures, Kaiser Permanente Ventures|